BACHEM HOLDING LTD header image

BACHEM HOLDING LTD

BANB

Equity

ISIN CH1176493729 / Valor 117649372

SIX Swiss Exchange (2026-11-06)
CHF 79.70-0.06%

BACHEM HOLDING LTD
UMushroom community rating:

star star star star star
4.14 3 votes No rating yet
NegativeNeutralPositive

About company

Bachem Holding Ltd is a Swiss company specializing in the development and manufacture of peptides and oligonucleotides for the pharmaceutical and biotechnology industries.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

56.4%1Y
15.5%3Y
-42.6%5Y

Performance

39.5%1Y
38.9%3Y
42.0%5Y

Volatility

Market cap

7278 M

Market cap (USD)

Daily traded volume (Shares)

58,184

Daily traded volume (Shares)

1 day high/low

58.85 / 57.65

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

4.14

3 votes
Performance:
starstarstarstarstar
3.43
Innovation:
starstarstarstarstar
4.00
Society:
starstarstarstarstar
3.86
Nature:
starstarstarstarstar
4.29
Conor Walsh
UK, 25 Oct 2026
star star star star star
Bachem is well positioned to benefit from growing demand for peptide manufacturing, particularly GLP-1 treatments. Its strong contract pipeline supports long-term growth, although high capital expenditure, margin pressure and a premium valuation limit near-term upside.
Cla Passo
Switzerland, 25 Mar 2025
star star star star star
chemie wird konsolidiert
Porntiva Sornprasit
Switzerland, 29 Nov 2024
star star star star star
Gut

EQUITIES OF THE SAME SECTOR

Biogen Inc
Biogen Inc Biogen Inc Valor: 1720684
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.81%USD 248.35
Zydus Lifesciences Limited
Zydus Lifesciences Limited Zydus Lifesciences Limited Valor: 29835501
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.12%INR 1,195.00
IPCA Laboratories Limited
IPCA Laboratories Limited IPCA Laboratories Limited Valor: 115718957
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.35%INR 1,942.95
AnaptysBio, Inc.
AnaptysBio, Inc. AnaptysBio, Inc. Valor: 29675116
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.91%USD 46.45
LeMaitre Vascular inc
LeMaitre Vascular inc LeMaitre Vascular inc Valor: 2755054
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.11%USD 80.89
GSK PLC
GSK PLC GSK PLC Valor: 120042705
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.16%USD 50.33
Glenmark Pharmaceuticals Limited
Glenmark Pharmaceuticals Limited Glenmark Pharmaceuticals Limited Valor: 3195888
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
4.32%INR 2,592.85
GSK PLC
GSK PLC GSK PLC Valor: 119642297
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%GBP 18.90
Hikma Pharmaceuticals PLC
Hikma Pharmaceuticals PLC Hikma Pharmaceuticals PLC Valor: 2324471
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.77%GBP 16.50
Piramal Pharma Limited
Piramal Pharma Limited Piramal Pharma Limited Valor: 114197705
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.17%INR 239.20